A panel of scientists with India’s Ministry of Environment said in a risk assessment of genetically modified mustard that the crop does not “pose any risk of causing any adverse effects on human and animal health and safety.” [1]
Mustard oil accounts for more than 10% of India’s cooking requirement of approximately 21 million metric tons.
The scientists have spoken, but not everyone is convinced that the information is accurate.
If you have a child that is restricted to a “special” diet because of food allergies or other health issues, you know how expensive it can be trying to tailor your meals and snacks so that he doesn’t wind up with hives, or worse. Two Kansas moms with lots of experience in trying to keep their kiddos healthy and happy without breaking the bank decided to do something about it.
First General Mills announced its plans to label GMOs, and now 2 more Big Food companies are following the company’s lead. Both Kellogg’s and Mars will now label many of their products with the words, “produced with genetic engineering” if they contain GMO ingredients, starting in mid-April.
Big Food Finally Bows to Consumer Pressure for GM Labeling
SAME café, short for So All May Eat, started 10 years ago in Denver, Colorado with a simple premise. The food served was to be mostly organic and locally-sourced, and if you couldn’t pay for it – well that didn’t matter so much. The café was more interested in presenting healthful culinary delights to all people (regardless of their ability to pay) than making tons of money. SAME, is in fact, the first non-profit restaurant in the city, and there are few like it across the country.
GM crops reportedly come with increasingly high costs and few benefits, and as a result, many farmers are refusing to plant them.
Pharmaceutical companies have been known to discredit natural, cheap solutions that compete with their high-dollar drugs. Now, the British Medical Journal has unraveled new research revealing how the makers of a cancer drug are blocking public access to a cheaper, safe, and effective alternative.
What happens when mega pharmaceutical companies get their new grip around one of the oldest asthma medications that many rely on for daily use? Based on historical data, it appears that one of the first action items is to exponentially increase the price of the same medication without any actual advancements of any kind. It’s a process that is involved with ‘repatenting.’
